Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 15, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 19, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001468818-26-000006
Filed / recorded
Oct 19, 2026, 10:51 PM UTC
Added to OQRO
Oct 19, 2026, 10:55 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
MiniMed Group, Inc.
Issuer CIK
2062583
Ticker
MMED
Reporting person
Kevin E Lofton
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Oct 15, 2026
Transaction code
A
Shares / units
836
Acquired / disposed
Acquired (A)
Shares owned after
40,409
Ownership form
Direct
Amendment
No
Footnotes from the filing
On October 15, 2026, MiniMed Group, Inc. ("MiniMed") issued shares of its common stock to the Reporting Person in connection with the completion of an exchange offer of up to an aggregate of 252,813,348 newly issued shares of common stock of MiniMed in exchange for outstanding ordinary shares of Medtronic plc ("Medtronic"). The final exchange ratio was 4.5939 shares of MiniMed common stock for each ordinary share of Medtronic accepted in the exchange offer. As a result, the Reporting Person received 836 shares of MiniMed common stock in exchange for 182 ordinary shares of Medtronic accepted in the exchange offer.
Includes shares of common stock to be issued in connection with the vesting of one or more restricted stock units.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.